Aligos Therapeutics (ALGS) Return on Assets (2020 - 2026)
Aligos Therapeutics' (ALGS) quarterly Return on Assets came in at 0.01% in Q1 2026, down 1.0% YoY from 0.01% in Q1 2025, and down 383.58% on a QoQ basis from 0.0% in Q4 2025.
Aligos Therapeutics (ALGS) Return on Assets (2020 - 2026) Analysis & Trends
Aligos Therapeutics (ALGS) has 7 years of Return on Assets data on file, last reported at 0.01% in Q1 2026.
- Quarterly Return on Assets fell 1.0% year-over-year to 0.01% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.01% (down 1.0% YoY) and the FY2025 annual result came in at 0.0%, up 1.0% from the prior year.
- Return on Assets declined to 0.01% in Q1 2026, from 0.0% in the prior quarter.
- In the past five years, Return on Assets ranged from a high of 0.0% in Q4 2025 to a low of 0.02% in Q4 2024.
- A 5-year average of 0.01% and a median of 0.01% in 2022 frame the typical range for Return on Assets.
- Annual changes were most pronounced in 2024 — Return on Assets slipped 1 bps — and 2025, when it gained 1 bps.
- Tracing ALGS's Return on Assets over 5 years: stood at 0.01% in 2022, then decreased by 20 bps to 0.01% in 2023, then plunged by 124 bps to 0.02% in 2024, then soared by 85 bps to 0.0% in 2025, then plunged by 384 bps to 0.01% in 2026.
- The last three Return on Assets figures came in at 0.01% (Q1 2026), 0.0% (Q4 2025), and 0.01% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.81 Bn | 131.96 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 86.56 Bn | 78.56 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 65.72 Bn | 60.53 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.75 Bn | 53.61 Bn | 52.00 Mn | 0.00% |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.76 Bn | 28.45 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 28.59 Bn | 10.19 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.63 Bn | 26.47 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.24 Bn | 26.40 Bn | - | 0.00% |
| 10 | Aligos Therapeutics | 66.76 Mn | 36.32 Mn | - | -0.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.01% |
| Mar 31, 2026 | -0.01% |
| Dec 31, 2025 | 0.00% |
| Sep 30, 2025 | -0.01% |
| Jun 30, 2025 | -0.01% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | -0.02% |
| Sep 30, 2024 | -0.01% |
| Jun 30, 2024 | -0.01% |
| Mar 31, 2024 | -0.01% |
| Dec 31, 2023 | -0.01% |
| Sep 30, 2023 | -0.01% |
| Jun 30, 2023 | -0.01% |
| Mar 31, 2023 | -0.01% |
| Dec 31, 2022 | -0.01% |
| Sep 30, 2022 | -0.01% |
| Jun 30, 2022 | -0.01% |
| Mar 31, 2022 | -0.01% |
| Dec 31, 2021 | -0.01% |
| Sep 30, 2021 | -0.01% |